HECLA MINING CO (HL)

US4227041062 - Common Stock

5.65  -0.08 (-1.4%)

After market: 5.65 0 (0%)

Fundamental Rating

3

Overall HL gets a fundamental rating of 3 out of 10. We evaluated HL against 157 industry peers in the Metals & Mining industry. Both the profitability and financial health of HL have multiple concerns. HL has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

HL had negative earnings in the past year.
HL had a positive operating cash flow in the past year.
In the past 5 years HL reported 4 times negative net income.
HL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.92%, HL is in line with its industry, outperforming 42.04% of the companies in the same industry.
With a Return On Equity value of -4.46%, HL perfoms like the industry average, outperforming 42.04% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.95%, HL is in line with its industry, outperforming 48.41% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HL is significantly below the industry average of 8.91%.
Industry RankSector Rank
ROA -2.92%
ROE -4.46%
ROIC 0.95%
ROA(3y)-0.95%
ROA(5y)-1.37%
ROE(3y)-1.42%
ROE(5y)-2.1%
ROIC(3y)1.5%
ROIC(5y)N/A

1.3 Margins

The Operating Margin of HL (4.82%) is comparable to the rest of the industry.
HL's Operating Margin has declined in the last couple of years.
HL has a Gross Margin (13.69%) which is in line with its industry peers.
In the last couple of years the Gross Margin of HL has grown nicely.
Industry RankSector Rank
OM 4.82%
PM (TTM) N/A
GM 13.69%
OM growth 3Y-31.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.34%
GM growth 5Y2.37%

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HL is destroying value.
Compared to 1 year ago, HL has more shares outstanding
HL has more shares outstanding than it did 5 years ago.
HL has a worse debt/assets ratio than last year.

2.2 Solvency

HL has an Altman-Z score of 2.16. This is not the best score and indicates that HL is in the grey zone with still only limited risk for bankruptcy at the moment.
HL has a Altman-Z score (2.16) which is in line with its industry peers.
A Debt/Equity ratio of 0.34 indicates that HL is not too dependend on debt financing.
HL has a worse Debt to Equity ratio (0.34) than 66.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.16
ROIC/WACC0.11
WACC8.35%

2.3 Liquidity

HL has a Current Ratio of 1.67. This is a normal value and indicates that HL is financially healthy and should not expect problems in meeting its short term obligations.
HL has a worse Current ratio (1.67) than 66.88% of its industry peers.
A Quick Ratio of 1.00 indicates that HL should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.00, HL is not doing good in the industry: 66.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1

3

3. Growth

3.1 Past

The earnings per share for HL have decreased strongly by -120.00% in the last year.
The Revenue has decreased by -2.95% in the past year.
HL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.90% yearly.
EPS 1Y (TTM)-120%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-2.95%
Revenue growth 3Y1.35%
Revenue growth 5Y4.9%
Sales Q2Q%-5%

3.2 Future

Based on estimates for the next years, HL will show a very strong growth in Earnings Per Share. The EPS will grow by 113.38% on average per year.
The Revenue is expected to grow by 7.29% on average over the next years.
EPS Next Y803.8%
EPS Next 2Y425.15%
EPS Next 3Y212.72%
EPS Next 5Y113.38%
Revenue Next Year16.16%
Revenue Next 2Y12.18%
Revenue Next 3Y7.29%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HL. In the last year negative earnings were reported.
HL is valuated rather expensively with a Price/Forward Earnings ratio of 22.09.
HL's Price/Forward Earnings ratio is in line with the industry average.
HL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.59.
Industry RankSector Rank
PE N/A
Fwd PE 22.09

4.2 Price Multiples

HL's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.97

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HL's earnings are expected to grow with 212.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y425.15%
EPS Next 3Y212.72%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.25%, HL is not a good candidate for dividend investing.
HL's Dividend Yield is comparable with the industry average which is at 2.66.
With a Dividend Yield of 0.25, HL pays less dividend than the S&P500 average, which is at 2.30.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

On average, the dividend of HL grows each year by 18.47%, which is quite nice.
HL has paid a dividend for at least 10 years, which is a reliable track record.
HL has decreased its dividend recently.
Dividend Growth(5Y)18.47%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

The earnings of HL are negative and hence is the payout ratio. HL will probably not be able to sustain this dividend level.
HL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-18.09%
EPS Next 2Y425.15%
EPS Next 3Y212.72%

HECLA MINING CO

NYSE:HL (7/26/2024, 7:04:00 PM)

After market: 5.65 0 (0%)

5.65

-0.08 (-1.4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.54B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.09
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.92%
ROE -4.46%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.82%
PM (TTM) N/A
GM 13.69%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.67
Quick Ratio 1
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-120%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y803.8%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.95%
Revenue growth 3Y1.35%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y